Renin-Angiotensin-Aldosterone System Inhibitors for Right Ventricular Dysfunction in Tetralogy of Fallot: Quo Vadis?

Circulation. 2018 Apr 3;137(14):1472-1474. doi: 10.1161/CIRCULATIONAHA.117.032285.
No abstract available

Keywords: Editorials; heart defects, congenital; heart diseases; heart failure; losartan; survival; tetralogy of Fallot.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Adult
  • Double-Blind Method
  • Humans
  • Losartan
  • Renin-Angiotensin System
  • Tetralogy of Fallot*
  • Ventricular Dysfunction, Right*

Substances

  • Losartan